Systematic review of the effectiveness of pharmacologic interventions to improve quality of life and well-being in people with dementia

Claudia Cooper, Naaheed Mukadam, Cornelius Katona, Constantine G. Lyketsos, Dan Blazer, David Ames, Peter Rabins, Henry Brodaty, Carlos De Mendonça Lima, Gill Livingston

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Objective: To review systematically, for the first time, the effectiveness of all pharmacologic interventions to improve quality of life and well-being in people with dementia. Design: Systematic review and meta-analysis. Methods: We systematically reviewed the 15 randomized controlled trials and one review that fitted predetermined criteria. We included studies that reported the outcomes quality of life, well-being, happiness, or pleasure. Measurements: We rated the validity of studies using a checklist. We calculated mean differences between intervention and control groups at follow-up. Results: None of the evaluated trials reported a significant benefit to quality of life or well-being for people with dementia when comparing those taking a drug or its comparator at follow-up (pooled weighted mean difference: 0.18 [95% confidence interval: -0.82 to 0.46]). Conclusion: We found no consistent evidence that any drug improves quality of life in people with dementia. We recommend that all dementia trials should include quality of life as an outcome, as this is important to patients, and cannot be presumed from improvements in cognition or other symptomatic outcomes, especially if the latter are small.

Original languageEnglish (US)
Pages (from-to)173-183
Number of pages11
JournalAmerican Journal of Geriatric Psychiatry
Volume21
Issue number2
DOIs
StatePublished - Feb 2013

Keywords

  • Dementia
  • Quality of life
  • Systematic review

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Systematic review of the effectiveness of pharmacologic interventions to improve quality of life and well-being in people with dementia'. Together they form a unique fingerprint.

Cite this